Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff84f0b84cc2bc634ec97c844a1caacc |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2525-301 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B40-20 |
filingDate |
2019-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eb496f6eb5463d16e453211c6cf064d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7be6e47cf5b586c97b1cc84844fe8114 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd0b43253c1efffe684cce2b580d12b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4986ff04d21d7cd0a37cb065f965be18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24d1f22a4987c03e3cec0433febcd006 |
publicationDate |
2019-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2019136253-A1 |
titleOfInvention |
Morphometric genotyping of cells using optical tomography for detecting tumor mutational burden |
abstract |
A method to develop one or more morphometric classifiers to identify a tumor mutation burden (TMB). The method provides a non-invasive method of characterizing TMB that is responsive to a tumor in its early stages of development and irrespective of the tumor size. The method allows targeting cancer therapy to the specific characteristics of the cancer that the patient may have, allowing more efficient cancer management with far fewer side effects. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110343748-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110343748-B |
priorityDate |
2018-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |